BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 16916608)

  • 1. Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly. A study of the Cancer of the Liver Italian Program (CLIP).
    Pignata S; Gallo C; Daniele B; Elba S; Giorgio A; Capuano G; Adinolfi LE; De Sio I; Izzo F; Farinati F; Del Naja C; Stanzione M; Castiglione F; Marone G; Cuomo O; Felder M; Gaeta GB; De Maio E; Di Maio M; Signoriello G; Perrone F;
    Crit Rev Oncol Hematol; 2006 Sep; 59(3):243-9. PubMed ID: 16916608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiomics and machine learning analysis by computed tomography and magnetic resonance imaging in colorectal liver metastases prognostic assessment.
    Granata V; Fusco R; De Muzio F; Brunese MC; Setola SV; Ottaiano A; Cardone C; Avallone A; Patrone R; Pradella S; Miele V; Tatangelo F; Cutolo C; Maggialetti N; Caruso D; Izzo F; Petrillo A
    Radiol Med; 2023 Nov; 128(11):1310-1332. PubMed ID: 37697033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Assessment and Cholangiocarcinoma: Diagnostic Management and Artificial Intelligence.
    Granata V; Fusco R; De Muzio F; Cutolo C; Grassi F; Brunese MC; Simonetti I; Catalano O; Gabelloni M; Pradella S; Danti G; Flammia F; Borgheresi A; Agostini A; Bruno F; Palumbo P; Ottaiano A; Izzo F; Giovagnoni A; Barile A; Gandolfo N; Miele V
    Biology (Basel); 2023 Jan; 12(2):. PubMed ID: 36829492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging Features of Main Hepatic Resections: The Radiologist Challenging.
    Cutolo C; Fusco R; Simonetti I; De Muzio F; Grassi F; Trovato P; Palumbo P; Bruno F; Maggialetti N; Borgheresi A; Bruno A; Chiti G; Bicci E; Brunese MC; Giovagnoni A; Miele V; Barile A; Izzo F; Granata V
    J Pers Med; 2023 Jan; 13(1):. PubMed ID: 36675795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy Assessment: A New Paradigm for Radiologists.
    Granata V; Fusco R; Setola SV; Simonetti I; Picone C; Simeone E; Festino L; Vanella V; Vitale MG; Montanino A; Morabito A; Izzo F; Ascierto PA; Petrillo A
    Diagnostics (Basel); 2023 Jan; 13(2):. PubMed ID: 36673112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Assessment and Pancreatic Cancer: Diagnostic Management and Artificial Intelligence.
    Granata V; Fusco R; Setola SV; Galdiero R; Maggialetti N; Silvestro L; De Bellis M; Di Girolamo E; Grazzini G; Chiti G; Brunese MC; Belli A; Patrone R; Palaia R; Avallone A; Petrillo A; Izzo F
    Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival and adverse events of elderly patients treated with sorafenib for hepatocellular carcinoma.
    Soria A; Calvo M; Casas M; Vidales Z; Muñoz-Martínez S; Sapena V; Puigvehi M; Canillas L; Guardeño R; Gallego A; Mínguez B; Horta D; Clos A; Montoliu S; Roget M; Reig M; Vergara M
    Front Oncol; 2022; 12():829483. PubMed ID: 35982971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Narrative Review on LI-RADS Algorithm in Liver Tumors: Prospects and Pitfalls.
    De Muzio F; Grassi F; Dell'Aversana F; Fusco R; Danti G; Flammia F; Chiti G; Valeri T; Agostini A; Palumbo P; Bruno F; Cutolo C; Grassi R; Simonetti I; Giovagnoni A; Miele V; Barile A; Granata V
    Diagnostics (Basel); 2022 Jul; 12(7):. PubMed ID: 35885561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined Hepatocellular-Cholangiocarcinoma: What the Multidisciplinary Team Should Know.
    Cutolo C; Dell'Aversana F; Fusco R; Grazzini G; Chiti G; Simonetti I; Bruno F; Palumbo P; Pierpaoli L; Valeri T; Izzo F; Giovagnoni A; Grassi R; Miele V; Barile A; Granata V
    Diagnostics (Basel); 2022 Apr; 12(4):. PubMed ID: 35453938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Web-Based Prediction Model for Cancer-Specific Survival of Elderly Patients With Early Hepatocellular Carcinoma: A Study Based on SEER Database.
    He T; Chen T; Liu X; Zhang B; Yue S; Cao J; Zhang G
    Front Public Health; 2021; 9():789026. PubMed ID: 35096742
    [No Abstract]   [Full Text] [Related]  

  • 11. Defining Undertreatment and Overtreatment in Older Adults With Cancer: A Scoping Literature Review.
    DuMontier C; Loh KP; Bain PA; Silliman RA; Hshieh T; Abel GA; Djulbegovic B; Driver JA; Dale W
    J Clin Oncol; 2020 Aug; 38(22):2558-2569. PubMed ID: 32250717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic resection for hepatocellular carcinoma in the octogenarian: is it justified?
    Lee CW; Chan KM; Tsai HI; Hsieh YC; Lin CY; Kuo YC; Hsu HY; Yu MC
    Aging (Albany NY); 2019 Mar; 11(5):1537-1550. PubMed ID: 30867335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic Body Radiation Therapy as an Alternative to Transarterial Chemoembolization for Hepatocellular Carcinoma.
    Sapir E; Tao Y; Schipper MJ; Bazzi L; Novelli PM; Devlin P; Owen D; Cuneo KC; Lawrence TS; Parikh ND; Feng M
    Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):122-130. PubMed ID: 29066120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma in elderly patients: challenges and solutions.
    Brunot A; Le Sourd S; Pracht M; Edeline J
    J Hepatocell Carcinoma; 2016; 3():9-18. PubMed ID: 27574587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma: epidemiology and risk factors.
    Kew MC
    J Hepatocell Carcinoma; 2014; 1():115-25. PubMed ID: 27508181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of hepatocellular carcinoma in the elderly.
    Borzio M; Dionigi E; Parisi G; Raguzzi I; Sacco R
    World J Hepatol; 2015 Jun; 7(11):1521-9. PubMed ID: 26085911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trans-arterial chemo-embolization is safe and effective for very elderly patients with hepatocellular carcinoma.
    Cohen MJ; Bloom AI; Barak O; Klimov A; Nesher T; Shouval D; Levi I; Shibolet O
    World J Gastroenterol; 2013 Apr; 19(16):2521-8. PubMed ID: 23674854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma in the elderly: clinical characteristics, treatment, survival analysis in Korean patients older than 70 years.
    Kim YJ; Jang BK; Kim ES; Chung WJ; Park KS; Cho KB; Hwang JS
    J Korean Med Sci; 2012 Oct; 27(10):1147-54. PubMed ID: 23091310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with the overall survival of elderly patients with hepatocellular carcinoma.
    Fujii H; Itoh Y; Ohnishi N; Sakamoto M; Ohkawara T; Sawa Y; Nishida K; Ohkawara Y; Yamaguchi K; Minami M; Okanoue T
    World J Gastroenterol; 2012 Apr; 18(16):1926-32. PubMed ID: 22563173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refusal of cancer-directed surgery strongly impairs survival of patients with localized hepatocellular carcinoma.
    Wang J; Wang FW
    Int J Surg Oncol; 2010; 2010():381795. PubMed ID: 22312489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.